Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersRole of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial HypertensionGlomerular Function and Structure in Living Donors: Lessons from Single Nephron StudiesRenin-angiotensin system blockade: Its contribution and controversyBlockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat gliomaSevere spruelike enteropathy associated with olmesartanSystemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptorsGene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulationAddition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritisHigh glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cellsThe transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cellsRenal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats.Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in miceUltrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.Mechanisms underlying renoprotection during renin-angiotensin system blockade.The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune/autoinflammatory syndrome induced by adjuvants.Angiotensin-converting enzyme gene and diabetes mellitus.Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Developmental alcohol exposure leads to a persistent change on astrocyte secretome.Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric miceInvolvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model.Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.Angiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway.Angiotensin II sustains brain inflammation in mice via TGF-betaRenin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusAngiotensin II: immunohistochemical study in Sardinian pterygium.Molecular mechanisms of renal allograft fibrosis.Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implicationsCaptopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host diseaseBeneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.Hypoxia and the extracellular matrix: drivers of tumour metastasisExperimental and clinical rationale for use of MMF in nontransplant progressive nephropathies.Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin IILoss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosisThe Ayurvedic Medicine Salacia oblonga Attenuates Diabetic Renal Fibrosis in Rats: Suppression of Angiotensin II/AT1 Signaling
P2860
Q24644869-D55C3135-6FC4-4228-8335-7FA92790DEC3Q26747017-912BDD6B-926D-4348-B0D0-559EBE082A44Q26752679-C6DF1744-236B-4C80-921D-10797FC95668Q26827221-0FC69CEA-35FB-423C-B58D-9F48EEC475A3Q28211260-1269BE34-3B8C-4957-AB47-27A117DDDA6BQ28269450-D10A80F8-1E84-4F4F-8E1D-C9908DF7A330Q28364369-3A16D88A-DEA0-4B38-B2D2-698DC1EC60B1Q28505894-6926B363-72CC-466C-A67B-78945DAEB7C4Q28565493-3A9B77E6-F4B3-48FC-B5BF-B62273E2A293Q28568580-92A90BF2-29C4-4A94-91DB-015C22ACA197Q28573182-EA2F2303-67F1-4AE9-9407-0D2705A9BE90Q30427565-12E97B35-7D54-4FB9-8A3C-02F44431AA73Q30439297-51AB3326-995A-4C9E-B9AD-B4EC968A38ADQ30448786-141B267F-A726-4CD3-905D-B8396C04EEC6Q30499402-3924C60D-44E0-4BD3-A5A9-1B88549BF690Q32032127-7C800946-5E1F-40A2-B141-33F06CD1E00EQ32032668-0401C851-96FC-495C-8870-5F5A1320219AQ33354622-A345448B-4ADB-4433-8E9E-19586792810CQ33677484-D511EA83-CBF1-47F1-A3CF-B66593EA9A53Q33786962-F482F4C1-1ED7-4D79-965B-BE52BA2B48E2Q33793187-1638BB32-0B42-4410-8636-B75A5C590256Q33800565-4D243E66-23F8-4D78-BDA3-6816B3A9499CQ33808763-EBC1DDF8-0301-45AC-8A0E-EF06BC9B6702Q33854391-76D47837-15E8-400D-9811-6CC02F0FE541Q33872629-E6157AAE-D7E5-4E16-B864-544BF20D7730Q33999588-6415FC3A-3E67-4F75-9C41-47F005A0804BQ34001304-8F456FB5-6B1B-49A0-8796-74352496C274Q34028682-E95C5225-62EE-4A24-AA54-DB56EA018363Q34124779-2DD524A6-13D3-4E72-87A9-86B85FC87378Q34325870-50112010-1A28-4132-90DA-98B7926711F0Q34421501-AA7F811D-563E-4A08-9FBC-D55082AE334DQ34556186-9DAD8DD7-4EFC-416A-A325-4C5723730B92Q34642815-A42C67EA-6854-49F9-8258-9740BB371783Q34769458-5F086DEE-7D58-4F72-BAA1-C8848D1719C1Q34770468-7E05EB2D-0916-461F-9F55-926A62E269C7Q34820282-A827666F-3285-4DF7-BCEB-35FDC4BBB87DQ34993934-AE00F3F0-620A-47F4-89C5-CCB6BECE07B4Q35023420-54394C5B-2BD0-4FEB-9A5C-D8240618A7ECQ35088385-F1D44BCA-B74A-41C7-B71F-7ED51555D388Q35109072-2322DC7E-6983-411F-B508-5BE45419082D
P2860
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@ast
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@en
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@nl
type
label
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@ast
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@en
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@nl
prefLabel
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@ast
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@en
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@nl
P2093
P2860
P356
P1476
Angiotensin II stimulates extr ...... at glomerular mesangial cells.
@en
P2093
P2860
P304
P356
10.1172/JCI117251
P407
P577
1994-06-01T00:00:00Z